Cocrystal Pharma Statistics Share Statistics Cocrystal Pharma has 10.25M
shares outstanding. The number of shares has increased by null%
in one year.
Shares Outstanding 10.25M Shares Change (YoY) n/a Shares Change (QoQ) n/a Owned by Institutions (%) 7.36% Shares Floating n/a Failed to Deliver (FTD) Shares 22 FTD / Avg. Volume 0.03%
Short Selling Information The latest short interest is 27.49K, so 0.27% of the outstanding
shares have been sold short.
Short Interest 27.49K Short % of Shares Out 0.27% Short % of Float 0.35% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -1.17 and the forward
PE ratio is -1.94.
Cocrystal Pharma's PEG ratio is
0.
PE Ratio -1.17 Forward PE -1.94 PS Ratio 0 Forward PS n/a PB Ratio 2.16 P/FCF Ratio -1.25 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Cocrystal Pharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 4.77,
with a Debt / Equity ratio of 0.19.
Current Ratio 4.77 Quick Ratio 4.77 Debt / Equity 0.19 Debt / EBITDA -0.1 Debt / FCF -0.11 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.59M Employee Count 11 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -13.53% in the
last 52 weeks. The beta is 2.28, so Cocrystal Pharma's
price volatility has been higher than the market average.
Beta 2.28 52-Week Price Change -13.53% 50-Day Moving Average 1.61 200-Day Moving Average 1.74 Relative Strength Index (RSI) 40.54 Average Volume (20 Days) 70,690
Income Statement
Revenue n/a Gross Profit -126K Operating Income -17.88M Net Income -17.5M EBITDA -17.43M EBIT -17.88M Earnings Per Share (EPS) -1.72
Full Income Statement Balance Sheet The company has 9.86M in cash and 1.81M in
debt, giving a net cash position of 8.05M.
Cash & Cash Equivalents 9.86M Total Debt 1.81M Net Cash 8.05M Retained Earnings -333.42M Total Assets 8.51M Working Capital 4.93M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -16.48M
and capital expenditures -8K, giving a free cash flow of -16.49M.
Operating Cash Flow -16.48M Capital Expenditures -8K Free Cash Flow -16.49M FCF Per Share -1.62
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields COCP does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for COCP is $6,
which is 308.2% higher than the current price. The consensus rating is "Buy".
Price Target $6 Price Target Difference 308.2% Analyst Consensus Buy Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Oct 11, 2022. It was a
backward
split with a ratio of 1:12.
Last Split Date Oct 11, 2022 Split Type backward Split Ratio 1:12
Scores Altman Z-Score -56.94 Piotroski F-Score 1
